Resumen de acción SYK
Stryker Corporation opera como empresa de tecnología médica.
| Puntuación del copo de nieve | |
|---|---|
| Valoración | 2/6 |
| Crecimiento futuro | 2/6 |
| Resultados anteriores | 5/6 |
| Salud financiera | 4/6 |
| Dividendos | 4/6 |
Recompensas
Análisis de riesgos
Competidores de Stryker Corporation
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | US$336.50 |
| Máximo en 52 semanas | US$361.41 |
| Mínimo de 52 semanas | US$249.98 |
| Beta | 0.92 |
| 11 mes Cambio | -1.35% |
| Variación en 3 meses | -3.69% |
| Cambio de 1 año | 12.92% |
| 3Variación en 3 años | 26.78% |
| Variación en 5 años | 61.72% |
| Variación desde la OPV | 62,023.04% |
Noticias y actualizaciones recientes
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Jun 30
Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80
Jun 19The Returns At Stryker (NYSE:SYK) Aren't Growing
Jun 16Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Jun 05Recent updates
A Look At The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
Jun 30Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80
Jun 19The Returns At Stryker (NYSE:SYK) Aren't Growing
Jun 16Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Jun 05Stryker: Margin Gains Should Drive Upside
May 31Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?
May 25Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings
May 14Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 02We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease
Apr 29Stryker: A Great Company At An Expensive Price
Apr 05Stryker's (NYSE:SYK) Dividend Will Be $0.80
Mar 26Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Mar 25Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns
Mar 14At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?
Feb 21Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80
Feb 10Stryker: A Dividend Growth Powerhouse I'd Like To Own
Feb 02Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results
Feb 02Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly
Jan 24Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today
Jan 02Stryker: Mako Shoulder And Spine Launches Are On The Way
Dec 31Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 22Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year
Dec 08Why Stryker Is An Awesome Healthcare Compounder
Nov 30Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?
Nov 10Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital
Oct 19Stryker: Don't Buy This Dividend Champion (Yet)
Oct 13Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)
Oct 08Is Stryker (NYSE:SYK) A Risky Investment?
Sep 26Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology
Aug 22Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Jul 18Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price
Jul 06These 4 Measures Indicate That Stryker (NYSE:SYK) Is Using Debt Reasonably Well
Jun 17Stryker: Good Prospects
Jun 14With EPS Growth And More, Stryker (NYSE:SYK) Makes An Interesting Case
May 24Should You Think About Buying Stryker Corporation (NYSE:SYK) Now?
May 01Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital
Apr 18Calculating The Fair Value Of Stryker Corporation (NYSE:SYK)
Apr 06Is Stryker (NYSE:SYK) Using Too Much Debt?
Feb 27Stryker: Typically Excellent, Typically Expensive
Feb 16Stryker Has A Slowing FCF Conversion And No Plans Of Share Buyback
Feb 07If EPS Growth Is Important To You, Stryker (NYSE:SYK) Presents An Opportunity
Feb 02Rentabilidad de los accionistas
| SYK | US Medical Equipment | Mercado US | |
|---|---|---|---|
| 7D | -0.8% | -0.9% | 0.5% |
| 1Y | 12.9% | -2.6% | 20.5% |
Rentabilidad vs. Industria: SYK superó a la industria US Medical Equipment, que obtuvo un rendimiento del -1% el año pasado.
Rentabilidad vs. Mercado: SYK obtuvo unos resultados inferiores a los del mercado US, que fueron del 22.3% el año pasado.
Volatilidad de los precios
| SYK volatility | |
|---|---|
| SYK Average Weekly Movement | 2.4% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 15.2% |
| 10% least volatile stocks in US Market | 2.8% |
Precio estable de las acciones: SYK no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de SYK (2%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1941 | 52,000 | Kevin Lobo | www.stryker.com |
Stryker Corporation es una empresa de tecnología médica. La empresa opera a través de dos segmentos, MedSurg y Neurotecnología, y Ortopedia y Columna Vertebral. El segmento de Ortopedia y Columna vertebral suministra implantes para su uso en sustituciones articulares totales, como cadera, rodilla y hombro, y cirugías de traumatismos y extremidades.
Resumen de fundamentos de Stryker Corporation
| Estadísticas fundamentales de SYK | |
|---|---|
| Capitalización bursátil | US$129.62b |
| Beneficios(TTM) | US$3.36b |
| Ingresos (TTM) | US$20.96b |
38.1x
Ratio precio-beneficio (PE)6.1x
Ratio precio-ventas (PS)¿Está SYK sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de SYK | |
|---|---|
| Ingresos | US$20.96b |
| Coste de los ingresos | US$7.55b |
| Beneficio bruto | US$13.42b |
| Otros gastos | US$10.05b |
| Beneficios | US$3.36b |
Últimos beneficios comunicados
Mar 31, 2024
Próxima fecha de beneficios
Jul 30, 2024
| Beneficios por acción (BPA) | 8.82 |
| Margen bruto | 63.99% |
| Margen de beneficio neto | 16.03% |
| Ratio deuda/patrimonio | 67.1% |
¿Cómo se ha desempeñado SYK a largo plazo?
Ver rendimiento histórico y comparativa